Mirum Pharmaceuticals, Inc. (MIRM) Operating cash flow 2019–2025
Mirum Pharmaceuticals, Inc. (MIRM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$55.8MFY2025 · since FY2019: -$39.4M → $55.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $55.8M | +440.7% |
| FY2024 | $10.3M | +114.6% |
| FY2023 | -$70.9M | +40.9% |
| FY2022 | -$120.1M | +9.5% |
| FY2021 | -$132.8M | -49.0% |
| FY2020 | -$89.1M | -126.3% |
| FY2019 | -$39.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice